Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung

Metastasectomy represents the standard treatment for improving survival in patients with lung metastases (LMs) from bone (BS) or soft-tissue sarcoma (STS). Recently, radiofrequency ablation (RFA) of the LMs has been proved to be a useful option which can promise the similar effect to metastasectomy....

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tomoki, Matsumine, Akihiko, Takao, Motoshi, Nakatsuka, Atsuhiro, Matsubara, Takao, Asanuma, Kunihiro, Sudo, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293497/
https://www.ncbi.nlm.nih.gov/pubmed/28203089
http://dx.doi.org/10.2147/OTT.S121562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293497/
https://www.ncbi.nlm.nih.gov/pubmed/28203089
http://dx.doi.org/10.2147/OTT.S121562

Ejemplares similares